Glycopeptide: Difference between revisions
Ostermayer (talk | contribs) No edit summary |
(Strip bold, add See Also and References) |
||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
==Adverse Effects== | ==Adverse Effects== | ||
* | * [[Red Man Syndrome]]: Flushing, rash, itching, hypotension during IV infusion; prevent with slow infusion. | ||
* | * Nephrotoxicity: Kidney damage, especially with high doses or concurrent nephrotoxic drugs; monitor renal function. | ||
* | * Ototoxicity: Hearing loss or tinnitus, more common with high levels or prolonged use. | ||
* | * Hematologic Effects: Neutropenia, thrombocytopenia, or anemia; usually reversible. | ||
* | * Hypersensitivity Reactions: Rash, fever, or severe reactions like Stevens-Johnson syndrome. | ||
* | * Gastrointestinal Issues: Nausea, vomiting, diarrhea (more with oral use). | ||
* | * Other: Phlebitis, elevated liver enzymes, or superinfections. | ||
==List of Glycopeptides== | ==List of Glycopeptides== | ||
| Line 18: | Line 18: | ||
{{Template:Clinically Utilized Antibiotics}} | {{Template:Clinically Utilized Antibiotics}} | ||
==References== | |||
<references/> | |||
[[Category:Pharmacology]] | [[Category:Pharmacology]] | ||
[[Category:ID]] | [[Category:ID]] | ||
==See Also== | |||
*[[Vancomycin]] | |||
*[[Antibiotics]] | |||
*[[MRSA]] | |||
Latest revision as of 09:11, 22 March 2026
Adverse Effects
- Red Man Syndrome: Flushing, rash, itching, hypotension during IV infusion; prevent with slow infusion.
- Nephrotoxicity: Kidney damage, especially with high doses or concurrent nephrotoxic drugs; monitor renal function.
- Ototoxicity: Hearing loss or tinnitus, more common with high levels or prolonged use.
- Hematologic Effects: Neutropenia, thrombocytopenia, or anemia; usually reversible.
- Hypersensitivity Reactions: Rash, fever, or severe reactions like Stevens-Johnson syndrome.
- Gastrointestinal Issues: Nausea, vomiting, diarrhea (more with oral use).
- Other: Phlebitis, elevated liver enzymes, or superinfections.
List of Glycopeptides
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
References